EP238: Two Perspectives, One Mission: Advancing the Conversation on Mold Illness and CIRS - Neil Nathan, MD and Ritchie Shoemaker, MD

🎧 Episode Summary

In this special episode, Neil Nathan, MD and Dr. Ritchie Shoemaker, MD come together to share their distinct perspectives on mold-related illness and Chronic Inflammatory Response Syndrome (CIRS).

Drawing on decades of clinical experience and research, they explore where their approaches converge and differ across diagnosis, urine mycotoxin testing, MARCoNS, GENIE, environmental assessment, Actinobacteria, nervous system regulation, VIP, treatment approaches, and overall recovery.

The conversation offers two evolving perspectives on complex chronic illness with a shared goal of helping patients regain health and resilience.

🧭 In This Episode

- Treatment models for mold illness and CIRS, including key drivers and foundational pillars of recovery

- HLA-DR testing and its role in susceptibility, clinical decision-making, and recovery potential

- Biotoxin blood markers for diagnosis, treatment planning, and monitoring progress

- Urine mycotoxin testing, including accuracy, interpretation, limitations, and clinical utility

- VCS, NeuroQuant, GENIE, and organic acids as tools for clinical assessment and treatment direction

- MARCoNS, the sinubiome, and their potential significance in mold-related illness and CIRS

- Environmental assessment using ERMI, HERTSMI-2, air sampling, and indoor environmental professionals